Please use this identifier to cite or link to this item:
|Title:||Long-term efficacy of a tele-health intervention for acute coronary syndrome patients with depression: 12-month results of the MoodCare randomized controlled trial.|
|Authors:||O'Neil, Adrienne;Taylor, Barr;Hare, David L;Sanderson, Kristy;Cyril, Sheila;Venugopal, Kamalesh;Chan, Bianca;Atherton, John J;Hawkes, Anna;Walters, Darren L;Oldenburg, Brian|
|Institutional Author:||on behalf of the MoodCare Investigator Team|
|Affiliation:||School of Medicine, Deakin University, Victoria, Australia School of Public Health and Preventive Medicine, Monash University, Victoria, Australia A.ONEIL@deakin.edu.au.|
Department of Psychiatry, Stanford University, CA, USA.
University of Melbourne and Department of Cardiology, Austin Hospital, Victoria, Australia.
Menzies Research Institute Tasmania, University of Tasmania, Australia.
School of Public Health and Preventive Medicine, Monash University, Victoria, Australia.
School of Medicine, Deakin University, Victoria, Australia.
Institute for Safety, Compensation and Recovery Research, Monash University, Victoria, Australia.
Department of Cardiology, The Royal Brisbane and Women's Hospital, Queensland, Australia Department of Medicine, University of Queensland, Queensland, Australia.
School of Public Health and Social Work, Queensland University of Technology, Queensland, Australia.
Department of Cardiology, The Price Charles Hospital, Queensland, Australia.
School of Public Health and Preventive Medicine, Monash University, Victoria, Australia School of Population and Global Health, University of Melbourne, Melbourne.
|Citation:||European Journal of Preventive Cardiology 2014; 22(9): 1111-20|
|Abstract:||Depression is common after a cardiac event; however it often remains untreated. Previously, we reported the efficacy and feasibility of a 6-month tele-health programme (MoodCare), which integrates depression management into a cardiovascular disease (CVD) risk reduction programme for Acute Coronary Syndrome (ACS) patients with low mood. Here, we evaluate the long-term efficacy of the programme at 12-month follow-up.A two-arm, parallel, randomized design to compare the long-term effects of 'MoodCare' (n = 61) to usual care (UC) (n = 60) at 12 months.121 ACS patients recruited from six hospitals in Victoria and Brisbane, Australia were randomized to a telephone-delivered cognitive behavioural therapy and risk-reduction programme or usual medical care. Mixed-model repeated measurements (MMRM) analysis was applied with results expressed as estimated marginal mean changes in depression and health-related quality of life (HRQOL) outcomes by group.After 12 months, treatment effects were observed for those with major depressive disorder (MDD) for PHQ-9 depression (MoodCare: mean score: 6.5; 95% CI: 4.9-8.0 versus UC: 9.3; 95% CI: 7.7-10.9, p = 0.012)) and SF-12 mental health scores (MoodCare: 42.5; 95% CI: 39.8-45.2 versus UC: 36.8; 95% CI: 34.1-39.6, p = 0.005). No beneficial treatment effects were observed in those with no MDD at baseline.After 12 months, MoodCare was superior to UC for improving mental health outcomes for those with a clinical diagnosis of major depression. Our findings support the implementation of depression-based interventions for cardiac patients with a clinical diagnosis of depression and provide evidence of longer term efficacy to one year.|
|Internal ID Number:||25159700|
acute coronary syndrome
cognitive behaviour therapy
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.